The Effect of Virtual Reality Application on Anxiety and Patient Satisfaction During Intrauterine Insemination (IUI)

NCT ID: NCT06346730

Last Updated: 2024-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-15

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will conduct as a randomized pretest-posttest study to examine the effect of virtual reality glasses (VRG) application during the IUI procedure on anxiety and patient satisfaction. The population of the research will consist of women who were treated with assisted reproductive techniques and underwent IUI at the infertility polyclinic of Ministry of Health Adana City Training and Research Hospital between May and December 2024 and who meet the research criteria. The research sample was calculated as a total of 90 people (at least 45 people in each group) using the power program. Data; Personal Information Form, Visual Assessment Scale (VAS), State Trait Anxiety Inventory (STAI) and Patient's Perception of Nursing Care Scale will be collected from women who agree to participate in the research. Virtual reality glasses will be applied to the intervention group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will conduct as a randomized pretest-posttest study to examine the effect of virtual reality glasses (VRG) application during the IUI procedure on anxiety and patient satisfaction. The population of the research will consist of women who were treated with assisted reproductive techniques and underwent IUI at the infertility polyclinic of Ministry of Health Adana City Training and Research Hospital between May and December 2024 and who meet the research criteria. The research sample was calculated as a total of 90 people (at least 45 people in each group) using the power program. Data; Personal Information Form, Visual Assessment Scale (VAS), State Trait Anxiety Inventory (STAI) and Patient's Perception of Nursing Care Scale will be collected from women who agree to participate in the research. These scales will be applied to both groups before and after Intrauterine Insemination (IUI).

Virtual reality glasses will be applied to the intervention group during intrauterine insemination (IUI).

Keywords: Virtual reality, anxiety, patient satisfaction, Intrauterine Insemination (IUI)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Virtual Reality Anxiety Patient Satisfaction Intrauterine Insemination (IUI)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The sample will divide into intervention and control groups
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Virtual reality glasses to intervention group

Virtual reality glasses to intervention group, randomized pretest-posttest

Group Type EXPERIMENTAL

Virtual reality glasses to intervention group

Intervention Type DEVICE

experimental and control ,a randomized pretest-posttest study to examine

control

Non-intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual reality glasses to intervention group

experimental and control ,a randomized pretest-posttest study to examine

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-45 age group
* Primary infertile,
* Able to speak and understand Turkish,
* Are cognitive, effective and have no problems preventing communication,
* Having no psychiatric problems,
* Not diagnosed with epilepsy (due to the possibility of virtual reality (VR) glasses triggering epileptic seizures),
* Women who volunteer to participate in the study will be recruited.

Exclusion Criteria

* Having a psychiatric problem,
* Diagnosed with epilepsy
* Those who want to leave the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Suleyman Demirel University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ayşe Sevim AKBAY KISA

Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Evşen ÇU NAZİK, professor

Role: STUDY_CHAIR

Cukurova University

Ayşe Sevim SU Akbay Kısa, Ph.D

Role: STUDY_CHAIR

Suleyman Demirel University

Ebru Var

Role: STUDY_CHAIR

Adana City Training and Research Hospital

Sefa ARLIER, professor

Role: STUDY_CHAIR

Adana City Training and Research Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Seda ÇU KARAÇAY YIKAR, assist

Role: CONTACT

05416265614 ext. nursing

Ayşe Sevim SU Akbay Kısa, Ph.D

Role: CONTACT

05435872734 ext. nursing

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

142-18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.